USPTO serial 79121314
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
CH-1228 Plan-Les-Ouates, CH
CH-1228 Plan-Les-Ouates, CH
CH-1228 Plan-Les-Ouates, CH
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for industrial and scientific use, including for diagnostic use; chemical reagents other than for medical or veterinary use; diagnostic preparations, other than for medical or veterinary use; chemical substances, namely, reagents for chemical analysis in laboratories | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations and substances, namely, antibiotics, anticonvulsants, antiepileptic preparations and substances for the treatment of cardiological diseases, bone diseases, oncology, gynecology, rhumatology, phlebology and dermatological disorders and diseases; chemical reagents for medical and veterinary use; diagnostic preparations for medical and veterinary use | SECTION 71 - CANCELLED | — |
| 035 | Administrative processing of applications for marketing release authorization and regulatory approval of pharmaceutical and medical products; electronic data collection and data submission services for commercial purposes provided in connection with clinical research, testing, trials and finalization of pharmaceutical products, medical devices and biotechnology | SECTION 71 - CANCELLED | — |
| 042 | Consulting in the field of pharmaceutical science; research, design and development in the medical and pharmaceutical field; development of medicines for others; conducting clinical and preclinical trials and supervision of clinical and preclinical trials; development of medicines in compliance with regulatory requirements; conducting clinical trials for others in the field of medicine compatibility; pharmacovigilance services for others, namely, monitoring the quality and efficacy of pharmaceutical preparations; consultancy in the field of medical and pharmaceutical research; providing advice in connection with clinical trial research, testing and evaluation of pharmaceutical products, medical devices and biotechnology; evaluating medicines of others to assure compliance with regulatory requirements; providing data analysis of data obtained in connection with clinical trial research and testing of pharmaceutical products, medical devices and biotechnology; scientific research relating to the evaluation of new medicines; development of pharmaceutical preparations, remedies and medicines; technological services, namely, scientific research, analysis and testing in the pharmaceutical and health care sector; scientific research and analysis, namely, conducting early evaluations in the field of new pharmaceutical preparations; scientific research and development in the pharmaceutical field; scientific research and development, namely, conducting clinical trials of medicines of others; product development in the field of medicine | SECTION 71 - CANCELLED | — |
| 044 | Consultancy in the field of medical treatments and advice in the pharmaceutical field | SECTION 71 - CANCELLED | — |
| 045 | Regulatory compliance consultancy in the field of pharmaceutical products, medical devices and biotechnology products | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 7, 2023 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 11, 2023 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Apr 5, 2023 | FINP | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 11, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 11, 2023 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jan 11, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 1, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| May 8, 2020 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 15, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 13, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 9, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 9, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 17, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 17, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 1, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 30, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 11, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 11, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 11, 2013 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 27, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 27, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 26, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 26, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 16, 2013 | ALIE | ASSIGNED TO LIE | — |
| Aug 14, 2013 | NREV | NOTICE OF REVIVAL - MAILED | — |
| Aug 14, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 14, 2013 | PETG | PETITION TO REVIVE-GRANTED | — |
| Aug 14, 2013 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| May 10, 2013 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| May 10, 2013 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Apr 20, 2013 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Feb 27, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 5, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 5, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 5, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 4, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 18, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 12, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 7, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |